Despite recent advances in cancer treatment, little impact has been made on curing as opposed
to controlling cancers over the last several decades. Part of the problem is that
investigators have an incomplete understanding of how tumours behave as they evolve and in
response to treatment. In this trial, the investigators hope to better understand the
evolution of BRAF melanoma in response to drugs a patient may have received such as
vemurafenib or dabrafenib. Importantly, the investigators want to understand how the tumours
evolve resistance to these drugs and whether this can be predicted through blood tests, in
particular of the circulating tumour DNA.
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9